Yahoo Web Search

Search results

    • Is Sage Therapeutics a Contrarian Buy?

      Is Sage Therapeutics a Contrarian Buy?

      Motley Fool· 9 months ago

      Monday was a dark day for Sage Therapeutics (NASDAQ: SAGE), a company that focuses on developing therapies for brain disorders. The stock plummeted by...

    • 3 Stocks Expecting Good News From the FDA

      3 Stocks Expecting Good News From the FDA

      Motley Fool· 2 years ago

      Good news from the Food and Drug Administration (FDA) can send biotech stocks into the stratosphere. Patrick Bafuma (Mirati Therapeutics): One company...

    • This is how much the new PPD pill will cost

      This is how much the new PPD pill will cost

      Motherly via Yahoo News· 6 months ago

      When the news of the Food and Drug Administration’s (FDA) approval of Zurzuvae (zuranolone), the first oral treatment for postpartum depression (PPD) was...